Bronchodilator delivery in acute airflow obstruction: A meta-analysis

Archives of Internal Medicine

Volumn 157, Issue 15, 1997, Pages 1736-1744

  Turner, Mark O ^a   Patel, Ameen ^b   Ginsburg, Shiphra ^b   FitzGerald, J Mark ^a,c  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c VANCOUVER HOSPITAL AND HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHODILATING AGENT; ORCIPRENALINE; SALBUTAMOL; TERBUTALINE;

AIRWAY OBSTRUCTION; ARTICLE; ASTHMA; BRONCHODILATATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FORCED EXPIRATORY VOLUME; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MEDICAL NEBULIZER; META ANALYSIS; METERED DOSE INHALER; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0030740911     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.157.15.1736     Document Type: Article

References (59)

1. Turner MO, Gafni A, Swan D, FitzGerald JM. A review and economic evaluation of bronchodilator delivery methods in hospitalized patients. Arch Intern Med. 1996;156:2113-2118.
2. Jasper AC, Moshenifar Z, Kahan S, Goldberg HS, Koerner SK. Cost-benefit comparison of aerosol bronchodilator delivery methods in hospitalized patients. Chest. 1987;91:614-618.
3. Summer W, Elston R, Tharpe L, Nelson S, Haponik EF. Aerosol bronchodilator delivery methods: relative impact on pulmonary function and cost of respiratory care. Arch Intern Med. 1989;149:618-623.
4. O'Reilly JF, Buchanan DR, Sudlow MF. Pressurized aerosol with conical spacer is an effective alternative to nebulizer in chronic stable asthma. BMJ. 1983;286:1548.
5. Gervais A, Begin P. Bronchodilatation with a metered-dose inhaler plus an extension, using tidal breathing vs jet nebulization. Chest. 1987;92:822-824.
6. Tarala RA, Madsen BW, Paterson JW. Comparative efficacy of salbutamol by pressurized aerosol and wet nebulizer in acute asthma. Br J Clin Pharmacol. 1980;10:393-397.
7. Bowton DL, Goldsmith WM, Haponik EF. Substitution of metered-dose inhalers for hand-held nebulizers: success and cost savings in a large, acute care hospital. Chest. 1992;101:305-308.
8. Newhouse MT, Dolovich M. Aerosol therapy: nebulizer vs metered dose inhaler. Chest. 1987;91:799-800.
9. Jenkins SC, Heaton RW, Fulton TJ, Moxham J. Comparison of domiciliary nebulized salbutamol and salbutamol from a metered-dose inhaler in stable chronic airflow limitation. Chest. 1987;91:804-807.
10. Hofford JM. Metered dose inhaler therapy for asthma, bronchitis, and emphysema. J Fam Pract. 1992;34:485-492.
11. Kacmarek RM, Hess D. The interface between patient and aerosol generator. Respir Care. 1991;36:952-976.
12. Matthys H. Inhalation delivery of asthma drugs. Lung. 1990;suppl:645-652.
13. Noseda A, Yernault JC. Sympathomimetics in acute severe asthma: inhaled or parenteral, nebulizer or spacer? Eur Respir J. 1989;2:377-382.
14. Tashkin DP. Dosing strategies for bronchodilator aerosol delivery. Respir Care. 1991;36:977-988.
15. Kisch GL, Paloucek FP. Metered dose inhalers and nebulizers in the acute setting. Ann Pharmacother. 1992;26:92-95.
16. Konig P. Spacer devices used with metered-dose inhalers. Chest. 1985;88:276-284.
17. McFadden ER. Therapy of acute asthma. J Allergy Clin Immunol. 1989;84:151-158.
18. Newhouse MT, Dolovich MB. Control of asthma by aerosols. N Engl J Med. 1986;315:870-874.
19. Dolovich MB, Newhouse MT. Aerosols: generation, methods of administration, and therapeutic applications in asthma. In: Middleton E, Reed CE, Ellis EF, et al, eds. Allergy: Principles and Practice. St Louis, Mo: Mosby - Year Book Inc; 1993: 712-739.
20. Kuhl DA, Agiri OA, Mauro LS. Beta agonists in the treatment of acute exacerbation of chronic obstructive pulmonary disease. Ann Pharmacother. 1994;28:1379-1388.
21. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis. 1987;136:225-244.
22. Ciba Guest Symposium. Terminology, definitions and classifications of chronic pulmonary emphysema and related conditions. Thorax. 1959;14:286-299.
23. Cayton RM, Webber B, Paterson JW, Clark TJH. A comparison of salbutamol given by pressure-packed aerosol or nebulization via IPPB in acute asthma. Br J Dis Chest. 1978;72:222-224.
24. Cohen J. Statistical Power Analysis for the Behavioural Sciences. Orlando, Fla: Academic Press Inc; 1977:24-27.
25. Bracken MB. Statistical methods for analysis of effects of treatment in overviews of randomized trials. In: Sinclair JC, Bracken MB, eds. Effective Care of the Newborn Infant. New York, NY: Oxford University Press Inc; 1992:13-18.
26. Dolovich M. Lung dose, distribution, and clinical response to therapeutic aerosols. Aerosol Sci Tech. 1993;18:230-240.
27. Johnson MA, Newman SP, Bloom R, Talaee N, Clarke SW. Delivery of albuterol and ipratropium bromide from two nebulizer systems in chronic stable asthma. Chest. 1989;96:1-10.
28. Zainudin BMZ, Biddiscombe M, Tolfree SEJ, Short M, Spiro SG. Comparison of bronchodilator responses and deposition patterns of salbutamol inhaled from a pressurised metered dose inhaler, as a dry powder, and as a nebulised solution. Thorax. 1990;45:469-473.
29. Colacone A, Afilalo M, Wolkove N, Kreisman H. A comparison of albuterol administered by metered dose inhaler (and holding chamber) or wet nebulizer in acute asthma. Chest. 1993;104:835-841.
30. Chalmers TC, Celano P, Sacks HS, Smith H. Bias in treatment assignment in controlled clinical trials. N Engl J Med. 1983;309:1358-1361.
31. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA. 1995;273:408-412.
32. Berenberg MJ, Baigelman W, Cupples LA, Pearce L. Comparison of metered-dose inhaler attached to an aerochamber with an updraft nebulizer for the administration of metaproterenol in hospitalized patients. J Asthma. 1985;22:87-92.
33. Berry RB, Shinto RA, Wong FH, Despars JA, Light RW. Nebulizer vs spacer for bronchodilator delivery in patients hospitalized for acute exacerbations of COPD. Chest. 1989;96:1241-1246.
34. Hodder RV, Calcutt LE, Leech JA. Metered dose inhaler with spacer is superior to wet nebulization for emergency room treatment of acute, severe asthma. Chest. 1988;94:52S.
35. Idris AH, McDermott MF, Raucci JC, et al. Emergency room treatment of severe asthma: metered-dose inhaler plus holding chamber is equivalent in effectiveness to nebulizer. Chest. 1993;103:665-672.
36. Maguire GP, Newman T, DeLorenzo LJ, Brown RB, Stone D. Comparison of a hand-held nebulizer with a metered dose inhaler-spacer combination in acute obstructive pulmonary disease. Chest. 1991;100:1300-1305.
37. Moss K, McDonald A, Ferrara L, Myles D, Brischetto M. Metered dose inhaler vs compressor driven nebulizer in the delivery of metaproterenol. Chest. 1985;88: 53S.
38. Salzman GA, Steele MT, Pribble JP, Elenbaas RM, Pyszczynski DR. Aerosolized metaproterenol in the treatment of asthmatics with severe airflow obstruction. Chest. 1989;95:1017-1020.
39. Turner JR, Corkery KJ, Eckman D, et al. Equivalence of continuous flow nebulizer and metered-dose inhaler with reservoir bag for treatment of acute airflow obstruction. Chest. 1988;93:476-481.
40. Beasley CRW, O'Donnell TV. Pear shaped spacer nebuhaler compared with nebulized solution for terbutaline administration in acute severe asthma. N Z Med J. 1985;98:854-855.
41. Greene AB, Jackson CL. Terbutaline metered-dose inhalation vs metaproterenol by handheld nebulization: a comparison in black inner-city COPD patients. J Natl Med Assoc. 1988;80:393-396.
42. Higgins RM, Cookson WOCM, Chadwick GA. Changes in blood gas levels after nebuhaler and nebulizer administration of terbutaline in severe chronic airway obstruction. Bull Eur Physiopathol Respir. 1987;23:261-264.
43. McKee RJ. Bronchodilator vehicles: a comparative study of aerosol metaproterenol administration methods. RT J Respir Care Practitioners. 1989;2:21-24.
44. Morgan MDL, Singh BV, Frame MH, Williams SJ. Terbutaline aerosol given through pear spacer in acute severe asthma. BMJ. 1982;285:849-850.
45. Morley TF, Marozsan E, Zappasodi SJ, et al. Comparison of beta adrenergic agents delivered by nebulizer vs metered dose inhaler with InspirEase in hospitalized asthmatic patients. Chest. 1988;94:1205-1210.
46. Ba M, Spier S, Lapierre G, Lamarre A. Wet nebulizer versus spacer and metered dose inhaler via tidal breathing. J Asthma. 1989;26:355-358.
47. Oxman AD, Guyatt GH. Guidelines for reading literature reviews. Can Med Assoc J. 1988;138:697-703.
48. Oxman AD, Cook DJ, Guyatt GH. Users' guides to the medical literature: how to use an overview. JAMA. 1994;272:1367-1371.
49. Oxman AD. Checklists for review articles. BMJ. 1994;309:648-651.
50. Kirshner B. Methodological standards for assessing therapeutic equivalence. J Clin Epidemiol. 1991;44:839-849.
51. Orwin RG. A fail-safe N for effect size. J Educ Stat. 1983;8:157-159.
52. Levitt MA, Gambrioli EF, Fink JB. Comparative trial of continuous nebulization versus metered-dose inhaler in the treatment of acute bronchospasm. Ann Emerg Med. 1995;26:273-277.
53. Hasselblad V, Mosteller F, Littenberg B, et al. A survey of current problems in meta-analysis. Med Care. 1995;33:202-220.
54. Wolf FM. Meta-analysis: Quantitative Methods for Research Synthesis. Beverly Hills, Calif: Sage Publications; 1986:37-39.
55. 1. Eur Respir J. 1992;5:975-981.
56. Davison AG, Fayers PM, Nunn AJ, Venables KM, Newman Taylor AJ. Number of patients required in lung function studies. Thorax. 1986;41:830-832.
57. Emerson JD, Burdick E, Hoaglin DC, Mosteller F, Chalmers TC. An empirical study of the possible relation of treatment differences to quality scores in controlled randomized clinical trials. Control Clin Trials. 1990;11:339-352.
58. Colditz GA, Miller JN, Mosteller F. How study design affects outcomes in comparisons to therapy, I: medical. Stat Med. 1989;8:441-454.
59. Beveridge RC, Grunfeld AF, Hodder RV, Verbeek PR for the CAEP/CTS Asthma Advisory Committee: Guidelines for the emergency management of asthma in adults. Can Med Assoc J. 1996;155:25-37.